A detailed history of Assetmark, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Assetmark, Inc holds 130,265 shares of MRK stock, worth $14.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
130,265
Previous 115,770 12.52%
Holding current value
$14.8 Million
Previous $15.3 Million 5.57%
% of portfolio
0.05%
Previous 0.05%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $1.79 Million - $1.93 Million
14,495 Added 12.52%
130,265 $16.1 Million
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $1.35 Million - $1.57 Million
11,935 Added 11.49%
115,770 $15.3 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $421,557 - $458,756
-4,208 Reduced 3.89%
103,835 $11.3 Million
Q3 2023

Oct 27, 2023

BUY
$102.95 - $114.33 $338,087 - $375,459
3,284 Added 3.13%
108,043 $11.1 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $2.57 Million - $2.8 Million
23,677 Added 29.2%
104,759 $12.1 Million
Q1 2023

May 05, 2023

BUY
$102.94 - $114.86 $494,729 - $552,017
4,806 Added 6.3%
81,082 $8.63 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $741,141 - $950,244
8,476 Added 12.5%
76,276 $8.46 Million
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $530,932 - $596,443
6,281 Added 10.21%
67,800 $5.84 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $2.8 Million - $3.17 Million
33,541 Added 119.88%
61,519 $5.61 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $505,895 - $567,076
6,882 Added 32.62%
27,978 $2.3 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $24.2 Million - $30.3 Million
-334,748 Reduced 94.07%
21,096 $1.62 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $817,295 - $898,819
11,402 Added 3.31%
355,844 $26.7 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $11.8 Million - $13 Million
-167,646 Reduced 32.74%
344,442 $26.8 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $29 Million - $34.2 Million
-421,343 Reduced 45.14%
512,088 $39.5 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $8.14 Million - $9.03 Million
113,386 Added 13.83%
933,431 $76.4 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $6.34 Million - $7.19 Million
86,690 Added 11.82%
820,045 $68 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $9.92 Million - $11.3 Million
140,886 Added 23.78%
733,355 $57.3 Million
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $33.5 Million - $46.4 Million
528,102 Added 820.45%
592,469 $45.6 Million
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $4.05 Million - $4.56 Million
52,143 Added 426.56%
64,367 $5.85 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $79,199 - $86,330
1,041 Added 9.31%
12,224 $1.03 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $189,685 - $221,598
2,716 Added 32.08%
11,183 $938,000
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $23,726 - $27,061
341 Added 4.2%
8,467 $704,000
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $58,128 - $67,457
891 Added 12.32%
8,126 $621,000
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $12,461 - $14,653
-216 Reduced 2.9%
7,235 $513,000
Q2 2018

Aug 01, 2018

SELL
$50.83 - $59.72 $20,077 - $23,589
-395 Reduced 5.03%
7,451 $452,000
Q1 2018

May 16, 2018

SELL
$50.96 - $59.23 $920,439 - $1.07 Million
-18,062 Reduced 69.72%
7,846 $427,000
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $415,541 - $496,202
-8,050 Reduced 23.71%
25,908 $1.46 Million
Q3 2017

Nov 08, 2017

SELL
$58.67 - $63.13 $430,285 - $462,995
-7,334 Reduced 17.76%
33,958 $2.18 Million
Q2 2017

Aug 15, 2017

BUY
N/A
3,088 Added 8.08%
41,292 $2.65 Million
Q1 2017

Sep 15, 2017

SELL
N/A
-2,654 Reduced 6.5%
38,204 $2.43 Million
Q4 2016

Sep 15, 2017

BUY
N/A
16,956 Added 70.94%
40,858 $2.41 Million
Q3 2016

Sep 15, 2017

SELL
N/A
-3,805 Reduced 13.73%
23,902 $1.49 Million
Q2 2016

Sep 15, 2017

BUY
N/A
11,034 Added 66.18%
27,707 $1.6 Million
Q1 2016

Sep 15, 2017

BUY
N/A
1,892 Added 12.8%
16,673 $882,000
Q4 2015

Sep 15, 2017

BUY
N/A
14,781
14,781 $781,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.